• SENSEX 76,374.25
    -243.19 (--0.32%)
  • BANKNIFTY 51,348.05
    520.55 (+1.02%)
  • Tejas Networks
    902.70 1,495.10(%)
  • Mazagon Dock
    2,700.00 2,929.98(%)
  • Kalyan Jewellers
    497.15 337.00(%)
  • TCS
    3,416.60 3,457.35(%)
  • Hind.Aeronautics
    4,270.00 5,675.00(%)
  • Adani Power
    534.80 896.75(%)
  • Bharat Electron
    286.75 340.35(%)
  • Tata Motors
    655.20 606.20(%)
  • Vodafone Idea
    8.06 6.60(%)
  • Zomato Ltd
    214.00 304.50(%)
  • Reliance Power
    44.44 54.25(%)
  • Aurobindo Pharma
    1,267.95 1,592.55(%)
  • Reliance Industr
    1,234.55 1,156.00(%)
  • ICICI Pru. BSE
    1,000.01 1,197.40(%)
  • Persistent Sys
    4,828.60 3,232.60(%)
  • HDFC Bank
    1,799.50 1,880.00(%)
  • Wockhardt
    1,424.20 489.20(%)
  • Jio Financial
    230.70 394.70(%)
  • Rail Vikas
    364.65 647.00(%)
  • Larsen & Toubro
    3,447.40 3,963.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

RPG Life Sciences Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Goenka R P
  • BSE Code : 29175.0
  • ISIN : INE105J01010
2,351.45 95 (4.21%)
  • As on 03 Apr 2025 (EOD)

  • Today’s Low

    2,222.00

  • Today’s High

    2,368.95

  • Open

    2,280.95

  • Perv Close

    2,256.55

  • 52W Low

    1,381.00

  • 52W High

    2,974.95

Key Indicators

  • P/E(TTM)

    40.63

  • Mar.Cap (₹Cr.)

    3,889.07

  • Div & Yield %

    0.68

  • Book Value(₹)

    229.39

  • Debt-Equity Ratio

    4.21

  • AGM Date

    02-Apr-2025

  • EPS

    57.77

  • P/E Ratio

    40.63

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    3,889.07

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    13.23

  • BV (₹)

    229.40

  • Sales( ₹ in Cr.)

    582.05

  • NP (in Cr.)

    86.89

  • NP Var(%)

    27.0

  • Div%

    200.0

  • CPS (₹)

    62.90

  • EPS (₹)

    52.50

  • Traded Value (₹ in Lakhs)

    3,882.20

  • 52 Week High

    2,974.95

  • 52 Week Low

    1,381.00

  • Price BSE

    2347.0

  • Price NSE

    2,351.00

  • Market Capital( in Cr.)

    3,882.20

  • P/C Ratio

    37.30

  • P/E Ratio

    44.70

  • Price Vs.BV

    52.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 582.05 512.81 440.16 389.14 375.57 330.16
Excise Duty 576.80 508.54 436.62 382.88 369.14 323.83
Net Sales 582.05 512.81 440.16 389.14 375.57 330.16
Other Income 7.21 4.80 2.99 0.91 0.73 0.80
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 589.26 517.61 443.15 390.05 376.30 330.96
EXPENDITURE :
Raw Materials 576.80 508.54 436.62 382.88 369.14 323.83
Power & Fuel Cost 576.80 508.54 436.62 382.88 369.14 323.83
Employee Cost 132.15 117.06 99.97 94.66 90.97 89.93
Other Manufacturing Expenses 16.32 13.31 9.64 5.30 15.59 12.37
Selling & Administrative Expenses 79.41 72.73 66.28 56.57 55.31 58.50
Miscellaneous Expenses 16.32 13.31 9.64 5.30 15.59 12.37
Less : Pre-operative Expenses Capitalised :
Total Expenditure 471.42 425.93 369.98 336.47 334.53 315.91
Operating Profit 41.49 36.15 36.09 31.58 26.79 25.76
Interest 0.45 0.31 0.52 0.79 1.75 3.99
Gross Profit 117.84 91.68 73.17 53.58 36.45 15.05
Depreciation 17.07 15.50 15.66 16.47 16.36 15.32
Profit Before Tax 117.84 91.68 73.17 53.58 36.45 15.05
Tax 32.54 24.35 22.76 17.15 10.10 2.84
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -2.36 -0.31 -1.07 -3.57 -2.66 1.40
Reported Net Profit 87.66 67.64 51.48 40.00 29.01 10.81
Extraordinary Items 117.84 91.68 73.17 53.58 36.45 15.05
Adjusted Net Profit 87.66 67.64 51.48 40.00 29.01 10.81
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 26.46 19.85 15.88 11.91 6.62 3.97
P & L Balance carried down 87.66 67.64 51.48 40.00 29.01 10.81
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 200.00 150.00 120.00 90.00 50.00 30.00
Dividend Per Share(Rs) 16.00 12.00 9.60 7.20 4.00 2.40
Earnings Per Share-Unit Curr 53.01 40.90 31.13 24.19 17.54 6.54
Book Value 26.46 19.85 15.88 11.91 6.62 3.97
Book Value(Adj)-Unit Curr 26.46 19.85 15.88 11.91 6.62 3.97

Shareholding Pattern

  • Promoter Group

    72.95%

  • Public Share Holding

    27.05%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 3,108,771 18.80 3,108,771 11
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 35,662 0.22 35,662 2
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 8,920,874 53.94 8,920,874 7
Others 0 0.00 0 0
Sub Total 12,065,307 72.95 12,065,307 20
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 1,844 0.01 3 7
Foreign Bank 150 0.00 150 1
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 214,626 1.30 214,626 45
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 34,660 0.21 34,660 1
Mutual Funds / UTI 574,659 3.47 574,659 5
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 391,187 2.37 391,187 4
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 1,217,126 7.36 1,215,285 63
2] Non Institution
Bodies Corporate 217,504 1.32 216,370 199
Clearing Members 633 0.00 633 3
Directors of their Relatives 1,010 0.01 1,010 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 128,630 0.78 128,358 750
Foreign Non Institution Other 2,850 0.02 0 2
Hindu Undivided Families 132,259 0.80 132,245 468
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 33,327 0.20 33,327 1
Individuals holding nominal share capital up to Rs. 1 lakh 2,544,100 15.38 2,392,918 23,361
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 182,546 1.10 182,546 1
Sub Total 3,256,582 19.69 3,100,980 24,808
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 16,539,015 100.00 16,381,572 24,891

Company Background

RPG Life Sciences LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • RPG Life Sciences Ltd
  • BSE Code : 29175.0
  • ISIN : INE105J01010

  • Incorporation Year

    2007

  • Registered Office

    RPG House
    463 Dr Annie Besant Road Worli, Mumbai,
    Maharashtra-400030

  • Telephone

    91-022-24981650

  • FAX

    91-022-24970127

  • Chairman

    H V Goenka

  • Managing Director

    Yugal Sikri

  • Company Secretary

    Rajesh Shirambekar

  • Auditor

    SRBC & Co LLP

  • Face Value

    8

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

RPG Life Sciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
RPG LifeScience. 2,347.30 589.26 582.05 49.07 34.25
Abbott India 29,572.60 6,097.18 5,848.91 47.09 44.71
Astrazeneca Phar 8,100.10 1,330.33 1,295.53 208.82 33.26
P & G Health Ltd 5,259.35 1,166.89 1,151.26 36.90 39.76
Glaxosmi. Pharma 2,776.60 3,530.73 3,407.25 55.21 44.44
Cipla 1,452.70 17,645.00 16,574.34 24.90 20.10
Amrutanjan Healt 645.10 437.58 421.23 37.81 20.84
Fermenta Biotec. 292.05 315.24 307.09 27.68 4.10
Guj. Themis Bio. 272.20 174.19 169.82 56.36 44.82
Bliss GVS Pharma 120.00 638.96 605.46 27.46 11.19
Ambalal Sarabhai 37.31 11.70 3.81 15.94 1.92